Neulasta®

Neulasta® is an Acute Radiation Syndrome anti-neutropenia cytokine to help those acutely exposed to high-dose radiation that damages the bone marrow. Also available as an on-body injector (Neulasta® Onpro®).

Notify me on updates of this product 

Availability: Commercially Available

+1 844 696 3852
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
USA
www.neulasta.com
Manufacturer
Amgen, Inc.
Product Name
Neulasta®
Detection Category
Radiological/Nuclear
Detection Method
Medical Countermeasure;
Application
Personal Protective Equipment;
Equipment Type
PPE
Product Synopsis
Neulasta® is an Acute Radiation Syndrome anti-neutropenia cytokine to help those acutely exposed to high-dose radiation that damages the bone marrow. Also available as an on-body injector (Neulasta® Onpro®).
Availability
Commercially Available
Technology Readiness Level (TRL)
9
Market Entry Date
2015
User Feedback Sources
Indifferent/No user feedback
Weight
<1 lb.
Transportability
Pocket Size
Material
6 mg/0.6 mL in a single-dose prefilled syringe for manual use only.
Operating Time
Immediate post-exposure use
Standards Met
FDA
Other Operational Parameters
Administered once a week
Training Required
<1 hour training
Manuals Available
Yes
Please enter contact info.
Email Address: 
Company: 
Name: 
Title: